Clinical Trial

Feasibility of Home Monitoring of Visual Function in DR

Completed
View on ClinicalTrials.gov →
Summary
Diabetes is a serious condition where patients can develop complications in their body including their eyes which can lead to sight loss. Patients with diabetes are encouraged to attend yearly screening appointments at which signs of Diabetic Retinopathy (DR) are assessed. Attendance at these appointments and at any follow-up appointments can be time-consuming and inconvenient for those working. Better ways to monitor changes in vision are needed. Therefore, we are hoping to develop a set of eye tests that a person with diabetes can complete at home on a smartphone in collaboration with researchers at OKKO Health.
Trial Details
NCT Number NCT07386613
Lead Sponsor Queen's University, Belfast
Collaborators: OKKO Health
Conditions Diabetes (DM), Diabetes Complication, Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetic Retinopathy (DR), Diabetes Pregnancy, Gestational Diabetes Mellitus in Pregnancy, Dialysis Patients
Enrollment 55 participants
Start Date 2023-09-09
Primary Completion 2024-06-20 (estimated)
Study Completion 2024-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-04